Your browser doesn't support javascript.
loading
Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation.
Woo, Hyeong Jung; Kim, Seung-Hoon; Kang, Hyo Jung; Lee, Soo-Hwan; Lee, Seung Joon; Kim, Jong Man; Gurel, Ogan; Kim, Soo Yeol; Roh, Hye Ran; Lee, Jungmin; Park, Yeonsoo; Shin, Hyun Young; Shin, Yong-Il; Lee, Sun Min; Oh, So Yeon; Kim, Young Zoon; Chae, Jung-Il; Lee, Seoyoung; Hong, Min Hee; Cho, Byoung Chul; Lee, Eun Sook; Pantel, Klaus; Kim, Hye Ryun; Kim, Minseok S.
Affiliation
  • Woo HJ; Department of New Biology, DGIST, Daegu 42988, Korea.
  • Kim SH; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Kang HJ; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Lee SH; JE-UK Institute for Cancer Research, JEUK Co. Ltd., Gumi-si 39418, Korea.
  • Lee SJ; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Kim JM; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Gurel O; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Kim SY; College of Transdisciplinary Studies, DGIST, Daegu 42988, Korea.
  • Roh HR; Department of New Biology, DGIST, Daegu 42988, Korea.
  • Lee J; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Park Y; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Shin HY; Department of New Biology, DGIST, Daegu 42988, Korea.
  • Shin YI; CTCELLS Inc., 206-C, R7, DGIST, Daegu 42988, Korea.
  • Lee SM; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Korea.
  • Oh SY; Department of Rehabilitation Medicine, Pusan National University School of Medicine, Yangsan 50612, Korea.
  • Kim YZ; Department of Rehabilitation Medicine, Pusan National University School of Medicine, Yangsan 50612, Korea.
  • Chae JI; Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Korea.
  • Lee S; Medical Oncology & Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan 50612, Korea.
  • Hong MH; Division of Neurooncology and Department of Neurosurgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Korea.
  • Cho BC; Department of Dental Pharmacology, School of Dentistry, Jeonbuk National University, Jeonju 54896, Korea.
  • Lee ES; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul 06273, Korea.
  • Pantel K; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim MS; Center for Breast Cancer, National Cancer Center, Goyang 10408, Korea.
Theranostics ; 12(8): 3676-3689, 2022.
Article de En | MEDLINE | ID: mdl-35664056
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules tumorales circulantes Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Theranostics Année: 2022 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules tumorales circulantes Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Theranostics Année: 2022 Type de document: Article